Dulaglutide Injection is generally used for blood glucose control in adults with type 2 diabetes mellitus, and is injected subcutaneously once a week. After the injection enters the body, it has the effects of promoting insulin secretion by pancreatic B cells, inhibiting glucagon secretion by A cells, suppressing appetite, delaying gastric emptying and reducing body weight. Dulaglutide Injection may cause nausea, vomiting, loss of appetite, belching and other stomach discomfort symptoms. Moreover, due to the complexity of the disease and individual differences, it is recommended to use it under the guidance of a doctor and not to use it blindly.